Amniotic membrane transplantation for symptomatic bullous keratopathy

Archives of Ophthalmology

Volumn 117, Issue 10, 1999, Pages 1291-1297

  Pires, Renato T F ^a   Tseng, Scheffer C G ^a,b   Prabhasawat, Pinnita ^c   Puangsricharern, Vilavun ^d   Maskin, Steven L ^e   Kim, Jae Chan ^f   Tan, Donald T H ^g  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c MAHIDOL UNIVERSITY   (Thailand)

^d KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^e Cornea and Ext Disease of the Eye ^*  (United States)

^f Chung Ang University College of Medicine   (South Korea)

^g SINGAPORE NATIONAL EYE CENTRE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMNION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; KERATOPATHY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TRANSPLANTATION;

EID: 0033391702     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.117.10.1291     Document Type: Article

References (41)

1. Liu GJ. Histopathological study of pseudophakic bullous keratopathy developing after anterior chamber of iris-supported intraocular lens implantation. Jpn J Ophthalmol. 1993;37:414-425.
2. Kenyon KR. The synthesis of basement membrane by the corneal epithelium in bullous keratopathy. Invest Ophthalmol Vis Sci. 1969;8:156-168.
3. Kenney MC, Chwa M. Abnormal extracellular matrix in corneas with pseudophakic bullous keratopathy. Cornea. 1990;9:115-121.
4. Ljubimov AV, Burgeson RE, Butkowski RJ, et al. Extracellular matrix alterations in human corneas with bullous keratopathy. Invest Ophthalmol Vis Sci. 1996; 37:997-1007.
5. Funderburgh JL. Decorin and biglycan of normal and pathologic human corneas. Invest Ophthalmol Vis Sci. 1998;39:1954-1964.
6. Ruben M. Soft contact lens treatment of bullous keratopathy. Trans Ophthalmol Soc U K. 1975;95:75-78.
7. Gasset AR. Bandage contact lens in the treatment of bullous keratopathy. Am J Ophthalmol. 1971;72:376-380.
8. Cormier G. Anterior stromal punctures for bullous keratopathy. Arch Ophthalmol. 1996;114:654-658.
9. Koenig SB. Annular keratotomy for the treatment of painful bullous keratopathy. Am J Ophthalmol. 1996;121:93-94.
10. Roal MI. Epikeratophakia for control of pediatric bullous keratopathy. J Cataract Refract Surg. 1998;13:59-62.
11. Thomann U, Meier-Gibbons F, Schipper I. Phototherapeutic keratectomy tor bullous keratectomy. Br J Ophthalmol. 1995;79:335-338.
12. Smith R. Surgical relief of bullous keratopathy (Gunderson's operation). Trans Ophthalmol Soc U K. 1965;85:307-316.
13. Alino AM, Perry HD, Kanellopoulos AJ, Donnenteld ED, Rahn EK. Conjunctival flaps. Ophthalmology. 1998;105:1120-1123
14. Lee S-H, Tseng SCG. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol. 1997;123:303-312.
15. Tsubota K, Satake Y, Ohyama M. et al. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol. 1996;122:38-52.
16. Shimazaki J, Yang H-Y, Tsubota K. Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns. Ophthalmology. 1997;104:2068-2076.
17. Tseng SCG, Prabhasawat P, Barton K, Gray T, Meller D. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol. 1998;116:431-441.
18. Tseng SCG, Prabhasawat P, Lee S-H. Amniotic membrane transplantation for conjunctival surface reconstruction. Am J Ophthalmol. 1997;124:765-774.
19. Prabhasawat P, Tseng SCG. Impression cytology study of epithelial phenotype of ocular surface reconstructed by preserved human amniotic membrane. Arch Ophthalmol. 1997;115:1360-1367.
20. Prabhasawat P, Barton K, Burkett G, Tseng SCG. Comparison of conjunctival autografts, amniotic membrane grafts and primary closure for pterygium excision. Ophthalmology. 1997;104:974-985.
21. Shimazaki J, Shinozaki N, Tsubota K. Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon. Br J Ophthalmol. 1998;82:235-240.
22. Kim JC, Lee D, Shyn KH. Clinical uses of human amniotic membrane for ocular surface diseases. In: Lass JH, ed. Advances in Corneal Research. New York, NY: Plenum Publishing Corp; 1997:117-134.
23. Franch A, Rama P, Lambiase A, Ponzin D, Caprioglio G. Human amniotic membrane transplantation. Invest Ophthalmol Vis Sci. 1998;39:S90.
24. Terranova VP, Lyall RM. Chemotaxis of human gingival epithelial cells to lamini: a mechanism for epithelial cell apical migration. J Periodontol. 1986;57:311-317.
25. Khodadoust AA, Silverstein AM, Kenyon KR, Dowling JE. Adhesion of regenerating corneal epithelium: the role of basement membrane. Am J Ophthalmol. 1968; 65:339-348
26. Sonnenberg A, Calafat J, Janssen H, et al. Integrin a6/b4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion. J Cell Biol. 1991; 113:907-917.
27. Quo M, Grinnell F. Basement membrane and human epidermal differentiation in vitro. J Invest Dermatol. 1989;93:372-378.
28. Streuli CH, Bailey N, Bissell MJ. Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity. J Cell Biol. 1991;115:1383-1395.
29. Kurpakus MA, Stock EL, Jones JCR. The role of the basement membrane in differential expression of keratin proteins in epithelial cells. Dev Biol. 1992;150: 243-255.
30. Barcellos-Hoff MH, Aggeler J, Ram TG, Bissell MJ. Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development. 1989;105:223-235.
31. Boudreau N, Sympson CJ, Werb Z, Bissell MJ. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science. 1995;267: 891-893.
32. Boudreau N, Werb Z, Bissell MJ. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. Proc Natl Acad Sci U S A. 1996;93:3500-3513.
33. Meller D, Tseng SCG. In vitro conjunctival epithelial differentiation on preserved human amniotic membrane. Invest Ophthalmol Vis Sci. 1998;39:5428.
34. Meller D, Pires RTF, Tseng SCG. Ex vivo preservation and expansion of human limbal epithelial progenitor cells by amniotic membrane [abstract]. Invest Ophthalmol Vis Sci. 1999;40(suppl):329.
35. Taylor RJ, Wang MX. Rate of re-epithelialization following amniotic membrane transplantation. Invest Ophthalmol Vis Sci. 1998;39:51038.
36. Azuara-Blanco A, Pillai CT, Sarhan A, Dua HS. Amniotic membrane transplantation for ocular surface reconstruction. Invest Ophthalmol Vis Sci. 1998;39: S428.
37. Sato H, Shimazaki J, Shinozaki K, Tsubota K. Role of growth factors for ocular surface reconstruction after amniotic membrane transplantation. Invest Ophthalmol Vis Sci. 1998;39(suppl):428.
38. Tseng SCG, Li D-Q, Ma X. Downregulation of TGF-β1, β2, β3, and TGF-β receptor II expression in human corneal fibroblasts by amniotic membrane. J Cell Physiol. 1999;179:325-335.
39. Wang M, Gray T, Prabhasawat P, et al. Corneal haze is reduced by amniotic membrane matrix in excimer laser photoablation in rabbits [abstract]. Invest Ophthalmol Vis Sci. 1997;38(suppl):S405.
40. Kim JS, Park SW, Kim JH, Lee, SI, Yang HN, Kim JC. Temporary amniotic membrane graft promotes healing and inhibits protease activity in corneal wound induced by alkali burns in rabbits [abstract]. Invest Ophthalmol Vis Sci. 1998:39 (suppl):90.
41. Na BK, Hwang JH, Shin EJ, Song CY, Jeong JM, Kim JC. Analysis of human amniotic membrane components as proteinase inhibitors for development of therapeutic agent of recalcitrant keratitis [abstract]. Invest Ophthalmol Vis Sci. 1998; 39(suppl):90.